RANE Global supported BC3 Technologies, the developer of SEAL™, a hemostatic spray, with a Türkiye-focused market assessment designed to evaluate commercialization potential within emergency medicine, trauma care, and combat-use environments. The engagement included a deep analysis of emergency response, military, and tactical healthcare usage data, enabling RANE Global to quantify the size of BC3’s addressable market in Türkiye. In parallel, we provided strategic insight into Türkiye’s regulatory requirements for medical devices, including approval pathways and compliance considerations, and identified and vetted potential Turkish partners capable of supporting distribution, integration, and long-term market presence.